Skip to main content
. 2017 Jun 29;12(6):e0180034. doi: 10.1371/journal.pone.0180034

Fig 5. Tumour therapy via in vivo production of Tnfα.

Fig 5

BALB/c or C57 mice bearing s.c. flank tumours were administered MG-Empty, MG-TNFα or vehicle (PBS). Tumours were monitored for changes in volume every other day. Tumour volume (%) relative to the first day of bacterial administration (day 0) is shown for (i) TRAMPC1 (ii) CT26 and (iii) RENCA (a-c). Statistical analysis at each time point is based on number of subjects alive. (d-e) Kaplan-Meier survival plots of each group starting from the first day of bacterial administration. *p < 0.05, **p < 0.01.